Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells
Patients with long-standing Diabetes mellitus can develop osteopenia and osteoporosis. We have previously shown that advanced glycation endproducts reduce the bone-forming activity of osteoblasts. Bisphosphonates are used for the treatment of various bone disorders, since they reduce osteoclastic fu...
Guardado en:
| Autores principales: | Gangoiti, María Virginia, Cortizo, Ana María, Arnol, Verónica, Felice, Juan Ignacio, McCarthy, Antonio Desmond |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2008
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/76584 |
| Aporte de: |
Ejemplares similares
-
Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation
por: McCarthy, Antonio Desmond, et al.
Publicado: (1999) -
Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development
por: McCarthy, Antonio Desmond, et al.
Publicado: (2001) -
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
por: McCarthy, Antonio Desmond, et al.
Publicado: (2004) -
AGE-R3/galectin-3 expression in osteoblast-like cells: Regulation by AGEs
por: Mercer, Natalia, et al.
Publicado: (2004) -
Advanced Glycation Endproducts and Alendronate Differentially Inhibit Early and Late Osteoclastogenesis <i>in vitro</i>
por: Gangoiti, María Virginia, et al.
Publicado: (2013)